Charles River Laboratories International, Inc. (CRL)

CRL Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 30, 2023	Dec 31, 2022	Dec 25, 2021	Dec 26, 2020	Dec 28, 2019
Cash & Equivalents	327.04	276.77	233.91	241.21	228.42	238.01
Cash & Cash Equivalents	327.04	276.77	233.91	241.21	228.42	238.01
Cash Growth	62.23%	18.32%	-3.03%	5.60%	-4.03%	21.78%
Receivables	786.98	780.38	752.39	642.88	617.74	514.03
Inventory	361.28	380.26	255.81	199.15	185.7	160.66
Other Current Assets	192.89	171.26	196.92	190.85	169.27	108.62
Total Current Assets	1,668	1,609	1,439	1,274	1,201	1,021
Property, Plant & Equipment	2,003	2,034	1,857	1,584	1,303	1,184
Long-Term Investments	243.54	243.81	311.6	201.35	0	0
Goodwill and Intangibles	3,898	3,959	3,805	3,773	2,597	2,230
Other Long-Term Assets	340.07	349.66	189.54	191.76	390.36	257.27
Total Long-Term Assets	6,485	6,586	6,164	5,750	4,290	3,671
Total Assets	8,153	8,195	7,603	7,024	5,491	4,693
Accounts Payable	129.68	168.94	205.92	198.13	122.48	111.5
Deferred Revenue	256.38	241.82	264.26	219.7	207.94	171.81
Current Debt	0	0	0	0	50.21	38.55
Other Current Liabilities	568.75	644.33	621.41	615.35	459.12	388.33
Total Current Liabilities	954.81	1,055	1,092	1,033	839.75	710.18
Long-Term Debt	3,079	3,066	3,097	2,917	2,085	1,966
Other Long-Term Liabilities	415.54	414.54	390.4	482.58	422.25	350.22
Total Long-Term Liabilities	3,494	3,481	3,488	3,399	2,507	2,316
Total Liabilities	4,449	4,536	4,579	4,432	3,347	3,026
Total Debt	3,079	3,066	3,097	2,917	2,135	2,004
Debt Growth	-2.64%	-1.00%	6.20%	36.58%	6.53%	20.17%
Retained Earnings	1,960	1,887	1,433	980.75	625.41	280.33
Comprehensive Income	-249.92	-196.43	-262.06	-164.74	-138.87	-178.02
Shareholders' Equity	3,640	3,597	2,976	2,535	2,115	1,635
Net Cash / Debt	-2,751.47	-2,789.61	-2,863.36	-2,675.32	-1,906.96	-1,766.45
Net Cash Per Share	-53.07	-54.22	-55.81	-52.02	-37.68	-35.55
Working Capital	713.38	553.58	347.45	240.91	361.38	311.14
Book Value Per Share	70.78	70.22	58.58	50.40	42.68	33.54

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).